An organ-donation campaign with a Brazilian football tie-in, and a UK managed-access company's series of documentary films, took top honors.
AstraZeneca is cutting 650 jobs in the US, "primarily in R&D," and consolidating its R&D operations at three "strategic R&D centers" in "bioscience clusters," academic and industrial beehives where the company can tap into concentrations of talent and infrastructure.
From tech shifts to talent, and from emerging markets to engaging with social media, agency execs offer their predictions for what the New Year will bring.
Industry pipelines might not be brimful of blockbusters, but after years of meager output, biopharma firms are poised to tap a cornucopia of innovative treatments as thirty-something New Molecular Entities launch each year through 2016.
McCann Healthcare Worldwide changed its name to McCann Health, and five of its six US agencies rebranded to align more closely with their parent, the network said today.
Total global pharma promotional spending fell 3.4% to $92.2 billion in 2011, according to Cegedim Strategic Data, led by a 4.7% decline in detailing spend.
Takeda is getting into vaccines with the launch of a dedicated global division that will make use of Nycomed A/S's business infrastructure in Europe and emerging markets.
The FDA issued Driving Innovation, a blueprint for fostering American biomedical innovation, reiterating a prior commitment to reform regulation and announcing policies aimed at facilitating personalized medicine.
AstraZeneca is reviewing its UK financial PR business amid media speculation on a possible acquisitions run in the US, reports our sister publication, PRWeek UK.
Roche, which is launching an HPV test, is sponsoring a blog by a UK healthcare reporter chronicling the process of getting a pap smear.
For all the talk of e-detailing and digitizing the sales force, a plurality of international healthcare professionals would rather get info about new treatments from flesh-and-blood reps than through any other channel, a survey found.
Teva is partnering with Procter & Gamble in an OTC drug marketing joint venture that will boast annual sales of more than $1 billion -- and which could ultimately be worth four times that, the companies say.
Staffers have been sent home and security has been bolstered at pharma offices located in Egypt's capital city, amid protests in Tahrir Square that have turned violent in recent days.
Merck and GSK are both increasing the number of sales reps operating in China, according to separate presentations given by the two companies. In both cases, added reps in emerging markets are helping to offset significant reductions in US sales forces, company executives said.
Global pharma market growth will pick up steam in 2011, with growth of 5%-7% to $880 billion, over 4%-5% growth in 2010, according to IMS Health.
Sanofi-Aventis put its global media buying and planning account up for review, a spokesperson for the company confirmed today.
Global sales of pharmaceuticals will grow at a rate of 5%-8% annually over the next five years, IMS Health forecasts -- even as products with sales of more than $142 billion lose patent protection in top markets, reducing drug spending by $80-$100 billion.
Atkins International Associates (AIA) launched a multifaceted life sciences website for marketers communicating to patients across the globe.
Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.
- Walgreen to vote on merger with Alliance Boots
- PBM deal on new hep.-C cocktail highlights drugmaker tolerance for discounts
- GSK shingles vax shaping up to compete with Merck's
- Five things for pharma marketers to know: Monday, December 22
- Five Big Shifts in Policy and Technology That Marketers Should Worry about in 2015